PARIS — World No. 1 Jannik Sinner was granted a medical timeout for apparent cramping during his second-round match at the 2026 French Open on Thursday, a decision that sparked immediate controversy and sharp criticism from TNT analyst and former player Jim Courier.

Sinner, who had dominated the first two sets against Argentina’s Juan Manuel Cerundolo, suddenly faltered in the third set while leading 5-1. After losing 15 consecutive points and appearing to grab his back, the Italian requested assistance. Following a conversation with the chair umpire in which Sinner mentioned concerns about dehydration, officials allowed him to take a medical timeout and briefly leave the court for treatment.

Courier, calling the match for TNT, strongly disagreed with the ruling. “This is absolute baloney,” he said on air. “That’s not fair. That’s not right.” He added later, “We love the top players, they drive the sport, but you’ve gotta apply the rules fairly. The rules are being bent for the top players.”

Tennis rules generally prohibit medical timeouts specifically for cramping, as the condition is often viewed as a fitness issue rather than an acute injury. The decision allowed Sinner time to recover, after which he returned to the court but ultimately dropped the third set, extending the match.

Match Context and Turning Point

Sinner entered the match as the clear favorite, having won the first two sets convincingly. His sudden physical decline at 5-1 in the third set shifted momentum dramatically in favor of Cerundolo, who capitalized on the Italian’s apparent discomfort to force a fourth set.

The timeout came at a critical juncture. While Sinner eventually regained some composure, the incident raised questions about consistency in rule enforcement, particularly for top-ranked players. Tennis analysts noted that lower-ranked players have occasionally been denied similar requests in past tournaments.

Sinner has dealt with occasional physical issues in the past, including a hip problem that affected his preparation for earlier events. However, he entered the 2026 French Open as the top seed and defending champion from previous hard-court successes, making the cramping episode unexpected.

Reactions and Rule Debate

Courier’s pointed criticism resonated widely on social media and among tennis observers. The former French Open champion emphasized that while he respects Sinner’s talent, the rules should apply equally regardless of ranking.

The International Tennis Federation and ATP Tour have clear guidelines on medical timeouts. Players may receive treatment for verifiable injuries or illnesses, but cramping is typically not eligible for such breaks to prevent strategic abuse. Umpires have discretion in borderline cases, which often leads to debate.

This is not the first time a high-profile player has faced scrutiny over medical timeouts at Roland Garros. Similar incidents in previous years involving other top players have prompted calls for stricter enforcement and clearer guidelines from governing bodies.

Sinner’s team has not publicly commented on the specific incident beyond standard post-match remarks. Cerundolo, who mounted a strong comeback attempt, focused on his own performance when speaking briefly with media after the match.

Broader Implications for Tennis

The controversy highlights ongoing challenges in professional tennis regarding player fitness, rule consistency, and the balance between athlete welfare and competitive fairness. As the sport’s physical demands increase with longer seasons and more powerful playing styles, cramping and fatigue-related issues have become more common.

Many players and coaches have called for better hydration protocols, improved scheduling, and potentially longer recovery periods between matches at Grand Slams. However, others argue that current rules already provide sufficient flexibility and that further leniency could undermine the sport’s integrity.

The French Open, known for its demanding clay courts and longer rallies, has historically seen more physical issues than faster surfaces. Organizers have increased medical support and cooling breaks in recent years, but debates over when such interventions cross into unfair advantages persist.

Sinner’s Path at Roland Garros

Despite the third-set setback, Sinner remained the strong favorite to advance. His overall dominance in 2025 and 2026, including multiple Grand Slam titles, has established him as the clear leader in men’s tennis. The incident, while controversial, did not appear to derail his campaign entirely, though it provided ammunition for critics questioning his resilience under pressure.

Cerundolo, ranked outside the top 50, played inspired tennis after the timeout and pushed the match longer than many expected. His performance earned respect from observers, even in defeat.

Fan and Media Response

Social media reaction was swift and divided. Supporters of Sinner argued that dehydration concerns justified the timeout and that the umpire made the correct on-court decision. Critics, including many neutral fans, sided with Courier’s assessment that the rules appeared to be applied inconsistently.

Broadcast clips of the umpire conversation and Courier’s commentary quickly went viral, amplifying the discussion. Tennis commentators on other platforms echoed concerns about fairness in high-stakes matches.

As the tournament progresses, officials may face increased scrutiny on medical timeout decisions. The French Tennis Federation has not issued an immediate statement on the specific incident.

Looking Ahead in the Tournament

Sinner’s match highlighted the physical toll of best-of-five set Grand Slam tennis. With temperatures rising in Paris during the second week, hydration and recovery management will remain critical for all players.

The controversy also comes at a time when tennis governing bodies are reviewing rules to modernize the sport while preserving its traditions. Any changes regarding medical timeouts would likely require extensive consultation with players, umpires and medical experts.

For now, the focus returns to on-court action. Sinner, despite the hiccup, remains a top contender for the 2026 French Open title. His ability to overcome physical challenges could become a defining narrative of his campaign.

The incident serves as a reminder of the fine line between legitimate medical needs and competitive strategy in elite tennis. As technology and sports science advance, expect continued debate over how best to balance player health with the spirit of fair competition.

American Eagle‘s two key brands are moving in different directions.

Revenue at the retailer’s namesake banner fell during its fiscal first quarter, even after it ramped up its marketing campaign with actress Sydney Sweeney. Meanwhile, sales at its intimates brand Aerie spiked during the quarter.

The trends at the retailer appeared to disappoint Wall Street, as shares tumbled more than 10% in extended trading.

In the three months ended May 2, comparable sales at the American Eagle banner fell 2%, far worse than the 3.1% growth that analysts had expected, according to StreetAccount. Meanwhile, comparable sales at Aerie soared 25%, beating expectations of 19.1%.

Net revenue for the American Eagle brand dropped 2% to $678.4 million, while Aerie revenue jumped about 34% to $480.83 million.

Combined, the business saw comparable sales grow 8%, short of expectations of 8.6%, according to StreetAccount. 

“While results at American Eagle were mixed, our teams are moving decisively to reignite the women’s business and strengthen product execution and brand positioning,” CEO Jay Schottenstein said in a news release

“Looking ahead, our priorities are clear. Despite continued consumer and macroeconomic uncertainty, we remain confident in our ability to navigate near-term headwinds,” he added.” We are focused on operational excellence and disciplined execution to drive long-term value for AEO and our shareholders.” 

Here’s how the apparel company performed during the fiscal first quarter compared with what Wall Street was anticipating, based on a survey of analysts by LSEG:

• Earnings per share: 14 cents vs. 12 cents expected
• Revenue: $1.20 billion vs. $1.19 billion expected

During the quarter, American Eagle posted net income of $23.53 million, or 14 cents per share, compared with a loss of $64.90 million, or 36 cents per share, a year earlier. 

Sales rose to $1.20 billion, up 10% from $1.09 billion a year earlier. 

American Eagle reiterated full-year guidance and issued an outlook for the current quarter. For the year, the company expects mid-single digit percentage comparable sales growth and an increase in gross margin.

In the second quarter, the retailer is expecting comparable sales to rise by a mid-to-high single digit percentage, compared to estimates of 6.5% growth, according to StreetAccount. It’s expecting its gross margin to be down compared to the prior year during the period.

During the quarter, American Eagle reignited its campaign with the “Euphoria” star Sweeney ahead of the summer shopping season, but took a tamer approach than the controversial campaign it launched last year under the slogan: “Sydney Sweeney has great jeans.” This time around, instead of cleavage and double entendres, Sweeney was all smiles in a modest, casual look on the beach. 

Though the two campaigns were different, the effect has been the same – neither led to a major increase in sales at American Eagle’s namesake banner. 

During a call with analysts, Schottenstein said marketing is leading to stronger engagement among new and existing customers, but moving forward, the company will “recalibrate spending” to ensure it’s getting the strongest return on investment. Later on, President Jennifer Foyle said marketing has driven “awareness and consideration” and now the company is “focused on conversion.”

During the quarter, selling, general and administrative costs, which include marketing, increased 11% to $376 million — which was in line with sales growth at Aerie but less so at American Eagle. For the back half of the year, the company said it plans to focus more of its marketing dollars on social influencers and other forms of digital media, which carry a higher propensity of conversion, the company said.

Beyond marketing woes, Foyle said the sales declines at American Eagle primarily came from the women’s bottoms segment — not having enough of the styles shoppers wanted and too much of the ones they didn’t.

“As merchants, we move quickly when we see opportunities and when we see misses. And we are already making adjustments. As we head into the crucial back-to-school season, we are refining our bottoms architecture, specifically optimizing key silhouettes and risers while leveraging our chase capabilities to inject fresh newness,” said Foyle. “At the same time, we are scaling high-demand categories within women’s tops to fully maximize ongoing consumer momentum.”

When asked how its core consumer was holding up given high gas prices and other macroeconomic pressures, Schottenstein said he thinks the U.S. economy is “very strong” and only going to get better.

“We think with gas prices hopefully will start settling down very shortly and with the, you know, current affairs, hopefully we’ll come to some type of finish,” said Schottenstein. “Hopefully it’ll be a very good finish for the world and we’re very optimistic on that.”

“As Americans struggle with the rising cost of gas, groceries, housing, and health care, President Trump’s priorities for taxpayer dollars are completely detached from the challenges families face every day,” Warner, a Democrat from Virginia, said in a statement.

Something is in the air – quite literally. Across the UK and beyond, sales of aroma therapy and scent-based wellness products have been climbing steadily for the better part of a decade, accelerating sharply in the years following the global disruption of the early 2020s.

Diffusers, essential oils, room sprays, scented candles, and inhalable aroma compounds have moved from the margins of the wellness market to its mainstream centre, and the momentum shows no sign of slowing.

The numbers reflect a genuine cultural shift. The global aromatherapy market was valued at over five billion dollars in the mid-2020s and is projected to continue growing at a compound annual rate that outpaces most comparable wellness categories. In the UK specifically, consumer interest in scent-based products has expanded well beyond the traditional spa and relaxation context into everyday home environments, workplace wellness, fitness recovery, and intimate settings.

What is driving this? The answer involves a confluence of science, lifestyle change, commercial innovation, and a growing consumer appetite for products that engage the body directly rather than through the intermediary of a screen or a pill.

The Science That Legitimised the Category

Aroma therapy has a credibility problem that it has been slowly but steadily resolving. For much of the twentieth century, the idea that inhaled scents could produce meaningful physiological or psychological effects sat uncomfortably between established medicine and the fuzzier edges of wellness culture. Enthusiasts were convinced; sceptics were unconvinced; and the research base was thin enough that neither side had to work very hard to maintain their position.

That has changed considerably. A growing body of peer-reviewed research has begun to map the mechanisms through which olfactory stimulation produces real, measurable effects on the body and mind. The olfactory system’s direct connection to the limbic region of the brain – the area governing emotion, memory, and stress response – provides a plausible and increasingly well-evidenced pathway through which scent-based compounds can influence mood, anxiety, and physiological state.

Lavender has accumulated perhaps the strongest evidence base. Multiple clinical studies have found that lavender inhalation produces statistically significant reductions in anxiety markers, heart rate, and cortisol levels. Peppermint has been studied for its effects on alertness and cognitive performance. Citrus compounds have shown promise in mood elevation research. The NHS acknowledges that while aromatherapy does not constitute medical treatment, the evidence for its role in supporting general wellbeing and stress management is sufficient to warrant serious consideration.

This gradual scientific legitimisation has had a significant commercial effect. Products that were once marketed almost entirely on lifestyle aspiration can now point to a growing body of research, and retailers have been quick to incorporate that credibility into how they present their ranges.

Lifestyle Change as a Market Driver

Science alone does not explain the scale of the growth. The timing of the aromatherapy boom aligns closely with broader shifts in how people relate to their home environments, their health, and their stress levels.

The disruption of normal routines during the early 2020s accelerated trends that were already in motion. With more people spending more time at home, the quality of the domestic sensory environment became a live concern rather than a background consideration. Investing in how a space smells – and how that scent makes its occupants feel – moved from an indulgence to a priority for a significant portion of the population.

At the same time, a wider cultural shift toward what might loosely be called embodied wellness has been gathering pace. The dominant wellness conversation of the previous decade had centred heavily on nutrition, fitness, and digital self-tracking. The limitations of that approach – its tendency toward abstraction, its reliance on willpower and data rather than sensation and experience – have prompted a countermovement toward products and practices that work through direct physical engagement.

Aroma therapy sits squarely in this countermovement. It requires no app, no subscription, no performance. It works through the oldest and most direct of the human senses, and it produces effects that are felt immediately rather than inferred from a graph.

Beyond Essential Oils: The Full Spectrum of the Category

Public discussion of aroma therapy tends to default to essential oils and diffusers, but the category is considerably broader than that framing suggests. Understanding its full scope helps explain both the scale of the market and the diversity of the people it serves.

At the gentler end sit the familiar products – reed diffusers, pillow sprays, bath oils, and scented candles. These products work primarily through ambient olfactory stimulation, gradually altering the scent profile of a space to produce cumulative mood and atmosphere effects. They are the entry point for most consumers and account for the largest share of market volume.

Further along the spectrum sit more targeted inhalable compounds, including room aromas based on alkyl nitrite formulations. These products operate through a more direct physiological mechanism – rapid vasodilation producing an immediate sensation of warmth and physical relaxation – and appeal to users seeking a fast-acting, intense, and short-lived effect rather than a gradual ambient one. Specialist retailers in this space, including long-established operations like Prowler Poppers, have seen sustained demand for alkyl nitrite-based room aromas over several decades, reflecting the enduring appeal of products that deliver an immediate and clearly felt physical response.

The breadth of the category is itself part of what has driven its growth. There is an aroma therapy product for virtually every use case, budget, and preference – from the three-pound supermarket reed diffuser to the premium essential oil blend from a specialist supplier. That accessibility at every price point has allowed the category to recruit consumers who might not have considered themselves wellness shoppers at all.

The Ritual Dimension

One of the most frequently underestimated factors in the appeal of aroma therapy products is the role of ritual. Research into the psychology of habit and behaviour consistently shows that deliberate, sensory-rich rituals are among the most effective mechanisms for signalling a shift in mental state – from stressed to calm, from distracted to focused, from fatigued to alert.

Aromatherapy products lend themselves to ritual in a way that few other wellness categories can match. The act of lighting a candle, filling a diffuser, or opening a bottle of room aroma is brief, tactile, and immediately rewarding. It requires no preparation, no equipment, and no expertise. And because scent is so powerfully linked to memory and association, a ritual repeated consistently with the same product begins to acquire a conditioned effect – the scent itself becomes a trigger for the mental state it has previously accompanied.

According to research highlighted by the Mental Health Foundation, sensory rituals and environmental cues play a meaningful role in supporting psychological wellbeing, particularly in managing the transition between different modes of daily life. The growing popularity of aroma therapy products reflects, in part, a widespread and intuitive understanding of this dynamic – one that consumers have reached through experience rather than instruction.

What Comes Next for the Category

The aroma therapy market is not simply growing – it is maturing. Early growth was driven largely by novelty and lifestyle aspiration. The next phase of growth is being driven by something more durable: a consumer base that has tried these products, experienced their effects, and built them into daily life.

That shift from novelty to habit is the most bullish possible signal for a product category. Habitual purchasers are more loyal, less price-sensitive, and more likely to expand their use into new product lines within the same category. They are also more likely to recommend products to others, generating the kind of organic word-of-mouth growth that marketing budgets cannot easily replicate.

The innovation pipeline reflects this maturity. Formulators are developing more targeted compounds, retailers are building more sophisticated product ranges, and the conversation around aroma therapy is becoming more nuanced – distinguishing between different mechanisms, different use cases, and different user needs with a precision that the early market lacked entirely.

What began as a niche interest has become a mainstream behaviour. Science has caught up, the lifestyle context has aligned, and the products have diversified to meet a demand that turns out to be both broad and deep. The rise of aroma therapy is not a trend in the pejorative sense – a passing enthusiasm that will fade as attention moves elsewhere. It is a genuine and durable shift in how people think about their sensory environment and what they are willing to invest in shaping it.

The air, it turns out, matters quite a lot.